BioLife Solutions appoints Cathy Coste to board and as audit committee chair
BioLife Solutions appointed Catherine Coste, a former Deloitte senior partner and licensed CPA, to its board effective March 18, 2025, increasing board membership to seven. She also replaces Joydeep Goswami as audit committee chair, with Goswami remaining a director and audit committee member. The filing describes the change as a board and governance update and does not report any financial results.
Key points
- Coste's appointment is effective March 18, 2025, and she serves until the 2025 Annual Meeting of Stockholders.
- Board membership increases to seven; Coste replaces Joydeep Goswami as audit committee chair.
- Coste retired from Deloitte in September 2020 after more than 32 years with the firm.
- Coste will receive the same prorated compensation as the company's other non-employee directors.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 2:07 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on March 24, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.